Back
Helen Of Troy 10K Form
Sell
23
HELE
Helen Of Troy
Last Price:
$22.46
Seasonality Move:
-0.31%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-01-08 | 10Q | HELE/Helen Of Troy Quarterly |
2023-10-04 | 10Q | HELE/Helen Of Troy Quarterly |
2023-07-10 | 10Q | HELE/Helen Of Troy Quarterly |
2023-01-06 | 10Q | HELE/Helen Of Troy Quarterly |
2022-10-06 | 10Q | HELE/Helen Of Troy Quarterly |
2022-07-08 | 10Q | HELE/Helen Of Troy Quarterly |
Receive HELE News And Ratings
See the #1 stock for the next 7 days that we like better than HELE
HELE Financial Statistics
Sales & Book Value
Annual Sales: | $1.9B |
---|---|
Cash Flow: | $45M |
Price / Cash Flow: | 4.58 |
Annual Sales: | $53.51 |
Price / Book: | 0.42 |
Profitability
EPS (TTM): | -14.52000 |
---|---|
Net Income (TTM): | $-333.2M |
Gross Margin: | $914.4M |
Return on Equity: | -21.76% |
Return on Assets: | -11.52% |
Helen Of Troy Earnings Forecast
Key Helen Of Troy Financial Ratios
-
The Gross Profit Margin over the past 41 years for HELE is 47.93%.
-
The Selling, General & Administrative Expenses for HELE have been equal to 36.98% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 41.96% of Operating Income.
-
The Net Earning history of HELE is 6.49% of Total Revenues.
-
Per Share Earnings over the last 41 years have been positive in 27 years.
Helen Of Troy Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Household Durables |
Sector: | Consumer Discretionary |
Current Symbol: | HELE |
CUSIP: | G4388N |
Website: | helenoftroy.com |
Debt
Debt-to-Equity Ratio: | 0.71 |
---|---|
Current Ratio: | 1.7 |
Quick Ratio: | 0.69 |
Price-to-Earnings
Trailing P/E Ratio: | 4.17 |
---|---|
Forward P/E Ratio: | 4.49 |
HELE Technical Analysis vs Fundamental Analysis
Sell
23
Helen Of Troy (HELE)
is a Sell
Is Helen Of Troy a Buy or a Sell?
-
Helen Of Troy stock is rated a SellThe current Helen Of Troy [HELE] share price is $22.39. The Score for HELE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.